Literature DB >> 30208383

Eosinopenia and Adverse Outcomes After Clostridium difficile Infections: Of Mice and Men.

Shuyan Wei1,2, Lillian S Kao1,2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30208383      PMCID： PMC6414281          DOI： 10.1001/jamasurg.2018.3200

Source DB:  PubMed          Journal:  JAMA Surg        ISSN： 2168-6254            Impact factor:   14.766


× No keyword cloud information.
  5 in total

Review 1.  Translation of research evidence from animals to humans.

Authors:  Daniel G Hackam; Donald A Redelmeier
Journal:  JAMA       Date:  2006-10-11       Impact factor: 56.272

2.  Changes in eosinophil count during bacterial infection: revisiting an old marker to assess the efficacy of antimicrobial therapy.

Authors:  B Davido; S Makhloufi; M Matt; R Calin; O Senard; C Perronne; A Dinh; J Salomon
Journal:  Int J Infect Dis       Date:  2017-06-13       Impact factor: 3.623

Review 3.  Small animal models for the study of Clostridium difficile disease pathogenesis.

Authors:  Melanie L Hutton; Kate E Mackin; Anjana Chakravorty; Dena Lyras
Journal:  FEMS Microbiol Lett       Date:  2014-01-07       Impact factor: 2.742

Review 4.  Prediction tools for unfavourable outcomes in Clostridium difficile infection: a systematic review.

Authors:  Claire Nour Abou Chakra; Jacques Pepin; Louis Valiquette
Journal:  PLoS One       Date:  2012-01-24       Impact factor: 3.240

5.  The binary toxin CDT enhances Clostridium difficile virulence by suppressing protective colonic eosinophilia.

Authors:  Carrie A Cowardin; Erica L Buonomo; Mahmoud M Saleh; Madeline G Wilson; Stacey L Burgess; Sarah A Kuehne; Carsten Schwan; Anna M Eichhoff; Friedrich Koch-Nolte; Dena Lyras; Klaus Aktories; Nigel P Minton; William A Petri
Journal:  Nat Microbiol       Date:  2016-07-11       Impact factor: 17.745
  5 in total
  1 in total

1.  Silent existence of eosinopenia in sepsis: a systematic review and meta-analysis.

Authors:  Yao Lin; Jiabing Rong; Zhaocai Zhang
Journal:  BMC Infect Dis       Date:  2021-05-24       Impact factor: 3.090
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.